1 Min Read
May 31 (Reuters) - Nicox SA
* Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.